Positive: Strong YTD performance for Broadcom, decline in Tesla stock price, double-digit growth for Eli Lilly.

From Nasdaq: 2024-06-29 11:05:51

Broadcom (AVGO), a leading semiconductor company, has had a strong YTD performance, boasting impressive revenue and EPS growth in Q2. With a dominant position in AI-related chips and wireless components for 5G handsets, AVGO is poised for continued success. Analysts have given the stock a “Strong Buy” rating with a target price indicating a 13.8% upside potential.

Tesla (TSLA), a key player in the EV market, has seen a decline in stock price due to disappointing delivery and margin numbers. Despite this, Tesla remains a market leader and is investing heavily in autonomous driving technology. Analysts have a consensus “Hold” rating for TSLA with an upside potential of approximately 56.7%.

Eli Lilly (LLY), a healthcare leader, has delivered double-digit revenue and earnings growth in the latest quarter. The company’s focus on drugs for diabetes and weight loss has propelled its stock price higher. With a strong pipeline of drugs, including a potential Alzheimer’s treatment, Eli Lilly is well-positioned for continued success.



Read more at Nasdaq: 3 Mega-Cap Stocks to Consider Before They’re Worth $1 Trillion